Australia's largest stock trading and investment forum Australia's #1 stock forum

DXB

1.28%

38.5¢ dimerix limited

I did some fact checking yesterday and came up with point 1 & 2...

First 41 Last

Share
Profile

Follow
Boffin99

2,843 Posts.

2893

02/01/24

09:11

Post #: 71686770
Share

Originally posted by vintage: ↑

"While I was embarrassing and stupid (thanks for your nice treatment): I did what I should have done in terms of sharing thoughts"

As far as credibility is concerned, you keep digging a bigger hole for yourself. And YES, you are 'embarrassing and stupid'.

First, you come on here, declaring yourself a 'newbie', even though you have been posting on HC for nearly 5 years - with your first post indicating that you were anything but a 'newbie' even then!

And, yes, your reference to Theranos (where their blood test product was in a category that required minimal FDA scrutiny) was stupid and irrelevant and, of course, only introduced as negative innuendo in order to unsettle the natives.

And now, you make arrogant ('may see a pop by gullible retail investors') and fluffed-up, holier than thou ('I did what I should have done in terms of sharing thoughts') posts based on poor and very inaccurate readings of the FSGS pipeline.

If you did your research intelligently - without giving away your thinly disguised strategy of loosening weak hands for your personal benefit - you would have discovered that:

1. VX-147 is only targeting a small proportion of FSGS sufferers (i.e. those with APOL1-medited FSGS or AMKD -which is only 1 of 36 known genetic causes of FSGS - and, further, does not include the non-genetic causes of FSGS)
2. VX-147 has not even completed recruitment for its Phase 2b trial and is therefore well over '6-12 months behind' DXB-200.

Why not just pay up now (when there is plenty of room for further growth) rather than play your half-baked and manipulative games for the purpose of acquiring cheaper shares?

Expand

I did some fact checking yesterday and came up with point 1 & 2 so good to see we are on the same page @Vantage

DXB Price at posting: 20.5¢ Sentiment: Buy Disclosure: Not Held
6 Upvote

0 Great analysis

Reply

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 37 more messages in this thread...

First 41 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 38.5¢		Change -0.005(1.28%)		Mkt cap ! $214.4M

Open	High	Low	Value	Volume
39.0¢	39.0¢	37.0¢	$503.5K	1.322M

Buyers (Bids)

No.	Vol.	Price($)
2	26318	38.0¢

Sellers (Offers)

Price($)	Vol.	No.
39.0¢	170072	6

View Market Depth

No.	Vol.	Price($)
1	1318	0.380
3	72579	0.375
4	134161	0.370
1	30000	0.365
4	27499	0.360

Price($)	Vol.	No.
0.390	140963	5
0.395	61740	2
0.400	115000	2
0.405	86528	4
0.410	56400	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

DXB (ASX) Chart

I did some fact checking yesterday and came up with point 1 & 2...

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I did some fact checking yesterday and came up with point 1 & 2...

Top Stories

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News